Detalles de la búsqueda
1.
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
Diabetes Obes Metab
; 26(6): 2229-2238, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456579
2.
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
Eur Heart J
; 44(14): 1231-1244, 2023 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36648242
3.
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
Eur Heart J
; 43(18): 1715-1727, 2022 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35165703
4.
Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people.
Eur Heart J
; 41(11): 1190-1199, 2020 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102402
5.
Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation.
Circulation
; 139(25): 2846-2856, 2019 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31046423
6.
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial.
Eur Heart J
; 40(46): 3771-3778a, 2019 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504399
7.
Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
Eur Heart J
; 40(34): 2899-2906, 2019 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30629157
8.
The prediction of therapy-benefit for individual cardiovascular disease prevention: rationale, implications, and implementation.
Curr Opin Lipidol
; 29(6): 436-444, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30234556
9.
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
Eur J Prev Cardiol
; 31(2): 182-189, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793098
10.
Long-term lifestyle change and risk of mortality and Type 2 diabetes in patients with cardiovascular disease.
Eur J Prev Cardiol
; 31(2): 205-213, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37774501
11.
Dietary habits and compliance with dietary guidelines in patients with established cardiovascular disease.
Eur J Clin Nutr
; 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38802604
12.
Impact of the 2021 European Society for Cardiology prevention guideline's stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease.
Eur J Prev Cardiol
; 31(6): 754-762, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38324720
13.
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Eur Heart J Cardiovasc Pharmacother
; 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38678009
14.
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.
Eur J Prev Cardiol
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38584392
15.
The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice.
Eur J Prev Cardiol
; 30(16): 1741-1747, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338108
16.
C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
J Am Coll Cardiol
; 82(5): 414-426, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37495278
17.
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.
Am J Cardiol
; 197: 13-23, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37218417
18.
Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
Int J Cardiol
; 379: 66-75, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36907452
19.
Physical exercise volume, type, and intensity and risk of all-cause mortality and cardiovascular events in patients with cardiovascular disease: a mediation analysis.
Eur Heart J Open
; 3(3): oead057, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37351547
20.
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
Eur J Prev Cardiol
; 30(1): 61-69, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208182